A genomics-informed mechanism-based pharmacokinetic/pharmacodynamic model of cefiderocol and ceftazidime/avibactam against carbapenem-resistant <i>Achromobacter xylosoxidans</i>. [PDF]
Arun B +6 more
europepmc +1 more source
High prevalence of bla<sub>NDM</sub> gene among a series of carbapenem-resistant Enterobacterales isolates from children less than one year old in Niger. [PDF]
Massir IN +10 more
europepmc +1 more source
Activity of novel antibiotics against dual metallo-Beta-lactamase producing Enterobacter hormaechei clinical isolates. [PDF]
Solar C +10 more
europepmc +1 more source
Use of Aztreonam-avibactam for infections caused by MBL-producing <i>Enterobacterales</i>. [PDF]
Medioli F +17 more
europepmc +1 more source
<i>In vitro</i> activity of aztreonam-nacubactam and cefepime-nacubactam against a global collection of clinically important Gram-negative Bacilli collected in 2021-2023. [PDF]
Karlowsky JA +4 more
europepmc +1 more source
Enhanced Efficacy of Cefiderocol With PolyTrim Combination Therapy in a Rabbit Model of Extensively Drug-Resistant Pseudomonas aeruginosa Keratitis. [PDF]
Romanowski EG +7 more
europepmc +1 more source
Vitamin B12 promotes cefiderocol resistance and small-colony variants in carbapenem-resistant <i>Acinetobacter baumannii</i>. [PDF]
Mezcord V +17 more
europepmc +1 more source
In vitro selection of cefiderocol-resistant mutants in Acinetobacter baumannii harbouring the most common carbapenemase genes. [PDF]
Raro OHF +4 more
europepmc +1 more source

